申请人:Lippard Stephen J.
公开号:US20110257261A1
公开(公告)日:2011-10-20
The present invention provides compositions, preparations, formulations, kits, and methods useful for treating subjects in need of therapeutic protocol, including subjects having cancer or at risk of developing cancer. Some embodiments of the invention may comprise a composition comprising a first component comprising a precursor to a therapeutically active platinum agent and a precursor to a second therapeutically active agent. The therapeutically active platinum agent and the second therapeutically active agent may dissociate from each other, thereby forming a first therapeutically active platinum agent and a second therapeutically active agent. The second therapeutically active gent may affect a cellular pathway of a cancer cell and may be substantially inactive towards non-cancerous cells.
本发明提供了用于治疗需要治疗方案的对象的组合物、制剂、配方、套装和方法,包括患有癌症或有癌症风险的对象。本发明的某些实施例可能包括一种组合物,该组合物包括第一组分,该第一组分包括治疗活性铂类药物的前体和第二治疗活性剂的前体。治疗活性铂类药物和第二治疗活性剂可以相互解离,从而形成第一治疗活性铂类药物和第二治疗活性剂。第二治疗活性剂可以影响癌细胞的细胞通路,并且对非癌细胞几乎没有活性。